Dmitry Balyasny’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,860
Closed -$232K 3319
2026
Q1
$232K Buy
+10,860
New +$226K ﹤0.01% 2652
2025
Q3
Sell
-106,586
Closed -$1.53M 3241
2025
Q2
$1.53M Buy
106,586
+90,619
+568% +$1.24M ﹤0.01% 1871
2025
Q1
$231K Buy
+15,967
New +$227K ﹤0.01% 2538
2023
Q3
Sell
-10,337
Closed -$147K 2538
2023
Q2
$147K Sell
10,337
-9,637
-48% -$135K ﹤0.01% 2096
2023
Q1
$298K Buy
+19,974
New +$303K ﹤0.01% 2111
2022
Q4
Sell
-11,407
Closed -$188K 3043
2022
Q3
$188K Buy
+11,407
New +$230K ﹤0.01% 2319
2021
Q2
Sell
-29,548
Closed -$753K 2188
2021
Q1
$753K Buy
+29,548
New +$757K ﹤0.01% 1316
2018
Q3
Sell
-115,049
Closed -$4.98M 1895
2018
Q2
$4.98M Sell
115,049
-148,489
-56% -$7.12M 0.02% 664
2018
Q1
$14.7M Sell
263,538
-305,019
-54% -$16.7M 0.06% 408
2017
Q4
$30.4M Buy
568,557
+364,020
+178% +$17.2M 0.09% 284
2017
Q3
$8.82M Sell
204,537
-855,710
-81% -$40.7M 0.03% 544
2017
Q2
$64M Buy
1,060,247
+1,048,047
+8,591% +$62.1M 0.26% 87
2017
Q1
$846K Buy
+12,200
New +$847K ﹤0.01% 1156
2015
Q4
Sell
-150,413
Closed -$11.6M 1354
2015
Q3
$11.6M Buy
+150,413
New +$12.1M 0.09% 306

Other funds holding MD

Dmitry Balyasny's MD Position: Q2 2026 in Review

Dmitry Balyasny sold out of Pediatrix Medical (MD) in Q2 2026, closing a stake of 10,860 shares — an estimated $232K sold.

Dmitry Balyasny first reported a position in MD in Q3 2015 and held it in 14 quarters. The position peaked at $64M in Q2 2017. 302 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Dmitry Balyasny reported no remaining Pediatrix Medical position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 10,860 Pediatrix Medical shares in Q2 2026, an estimated $232K.
  • Dmitry Balyasny first reported a position in Pediatrix Medical in Q3 2015 and held it in 14 quarters.
  • Dmitry Balyasny's Pediatrix Medical position peaked at $64M in Q2 2017.
  • 302 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.